Oncocyte Corporation Stock price
Is Oncocyte Corporation a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 9,127 stocks worldwide.
Key metrics
Oncocyte Corporation Stock Analysis
Analyst Opinions
8 Analysts have issued a Oncocyte Corporation forecast:
Analyst Opinions
8 Analysts have issued a Oncocyte Corporation forecast:
Don't miss a Thing! We will send you all news about Oncocyte Corporation directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Company Profile
OncoCyte Corp. is a molecular diagnostics company, which engages in the development and commercialization of diagnostic tests for the detection of cancer, including molecular diagnostic services to pharmaceutical customers. Its products include DetermaRx and DetermaIO. The firm also offers pharmaceutical services like multi-analyte test development and clinical trial services. The company was founded in September 2009 and is headquartered in Alameda, CA.
| Head office | United States |
| CEO | Mr. Riggs |
| Employees | 48 |
| Founded | 2009 |
| Website | oncocyte.com |


